Oncology Target Discovery
Causaly has scoured hundreds of thousands of biomedical papers, distilling decades of research into a concise, accessible article pack
Report
In the challenging world of oncology research, over 95% of drugs fail in clinical trials. With pivotal trials averaging $32 million, the need for precision and accuracy has never been greater.
Our latest Article Pack focuses on Oncology as a therapeutic area, providing you with the latest targets insights with the aim of enhancing your research efforts through improved decision-making and reduced bias.
Discover insights on:
- Identify 6,000+ targets for blood cancer, including microRNAs
- Explore clinical trial evidence for CD117 as a target for bladder cancer
- Prioritize 100+ targets for breast cancer studied in animal models
- And more...
Request your copy of
Oncology Target Discovery
Fill out the form below to access the full report.